GMS6551 FINAL EXAM REVIEW EXAM QUESTIONS AND
ANSWERS WITH COMPLETE SOLUTIONS VERIFIED
What is the primary endpoint of Phase One clinical trials?
To establish the dose and schedule for subsequent Phase Two trials.
List three secondary endpoints commonly investigated in Phase One trials.
Drug kinetics, metabolism, and pharmacodynamics.
Why are patents crucial in protecting intellectual property?
Because they grant exclusive rights to the inventor, preventing others from using,
making, or selling the invention without permission.
Under which act are federal funding recipients obligated to protect their
intellectual property?
Bayh-Dole Act.
What components are included in an Investigational New Drug (IND) application?
Preclinical and translational work, manufacturing information, and the clinical protocol
for the proposed drug.
Who must approve the clinical trial before it can be initiated?
Institutional Review Board (IRB)
What are some of the problems associated with traditional Phase One trials?
The maximum tolerated dose (MTD) may not always be the most rational endpoint, and
they often focus on monotherapies, which may not reflect real-world clinical use.
Additionally, they may not be suitable for rare diseases or chronic drug administration.
,Explain the concept of "Fast Tracking" in drug development.
Involves relaxing some stringent guidelines by the FDA in certain situations, prioritizing
first-in-class therapies or diseases with no effective standard of care to expedite drug
development.
How can alternative dosing strategies improve Phase One trials?
Alternative dosing strategies, such as measuring the biochemical effect or using
surrogate markers, can help optimize drug dosing and provide valuable insights into
drug efficacy and target validation.
What role do pharmacodynamics and biomarkers play in optimizing drug dosing?
Help researchers understand the drug's effects on the body and can indicate whether
the drug is hitting its intended target, helping to optimize drug dosing.
Why is following Good Clinical Practice and Good Manufacturing Practice
essential in clinical trials?
Ensures standardized guidelines for clinical trial design and drug manufacturing,
generating reliable and meaningful results for future clinical studies.
What is the difference between preclinical research and translational research?
Preclinical research involves optimizing and testing therapies in animal models, while
translational research focuses on moving discoveries from preclinical settings to clinical
applications in humans.
How does preclinical research contribute to the development of Phase One trials?
Preclinical research provides essential information about drug efficacy and safety in
animal models, guiding the design and dose selection for Phase One clinical trials.
, What was the success rate for new drugs in 1985, and how did it change by the
year 2000?
14%, and it decreased to 8% by the year 2000.
Why were phase zero trials introduced by the FDA in 2006?
To address the challenges in drug development, aiming to gather pharmacokinetic and
pharmacodynamic data early on and identify potential drug candidates for further study.
How does the use of very low drug doses in phase zero trials contribute to their
advantages?
Makes them less resource and time-intensive and usually involves no toxicity, allowing
for the selection of promising drug candidates without starting over from scratch.
What ethical considerations must be addressed in phase zero trials?
Must be aware that there is no possibility of therapeutic efficacy, and their participation
may disqualify them from subsequent clinical trials. Physicians must ensure a smooth
transition to appropriate treatments if needed.
What is the main goal of phase zero trials in drug development?
To gather pharmacokinetic and pharmacodynamic data early in drug development to
identify potential drug candidates for further study.
How did the cost of drug development change between 1985 and 2000, and what
impact did it have on drug development?
Increased by 55% between 1985 and 2000, making drug development riskier and more
expensive.
What advantage does using low drug doses in phase zero trials offer over
traditional drug development approaches?
ANSWERS WITH COMPLETE SOLUTIONS VERIFIED
What is the primary endpoint of Phase One clinical trials?
To establish the dose and schedule for subsequent Phase Two trials.
List three secondary endpoints commonly investigated in Phase One trials.
Drug kinetics, metabolism, and pharmacodynamics.
Why are patents crucial in protecting intellectual property?
Because they grant exclusive rights to the inventor, preventing others from using,
making, or selling the invention without permission.
Under which act are federal funding recipients obligated to protect their
intellectual property?
Bayh-Dole Act.
What components are included in an Investigational New Drug (IND) application?
Preclinical and translational work, manufacturing information, and the clinical protocol
for the proposed drug.
Who must approve the clinical trial before it can be initiated?
Institutional Review Board (IRB)
What are some of the problems associated with traditional Phase One trials?
The maximum tolerated dose (MTD) may not always be the most rational endpoint, and
they often focus on monotherapies, which may not reflect real-world clinical use.
Additionally, they may not be suitable for rare diseases or chronic drug administration.
,Explain the concept of "Fast Tracking" in drug development.
Involves relaxing some stringent guidelines by the FDA in certain situations, prioritizing
first-in-class therapies or diseases with no effective standard of care to expedite drug
development.
How can alternative dosing strategies improve Phase One trials?
Alternative dosing strategies, such as measuring the biochemical effect or using
surrogate markers, can help optimize drug dosing and provide valuable insights into
drug efficacy and target validation.
What role do pharmacodynamics and biomarkers play in optimizing drug dosing?
Help researchers understand the drug's effects on the body and can indicate whether
the drug is hitting its intended target, helping to optimize drug dosing.
Why is following Good Clinical Practice and Good Manufacturing Practice
essential in clinical trials?
Ensures standardized guidelines for clinical trial design and drug manufacturing,
generating reliable and meaningful results for future clinical studies.
What is the difference between preclinical research and translational research?
Preclinical research involves optimizing and testing therapies in animal models, while
translational research focuses on moving discoveries from preclinical settings to clinical
applications in humans.
How does preclinical research contribute to the development of Phase One trials?
Preclinical research provides essential information about drug efficacy and safety in
animal models, guiding the design and dose selection for Phase One clinical trials.
, What was the success rate for new drugs in 1985, and how did it change by the
year 2000?
14%, and it decreased to 8% by the year 2000.
Why were phase zero trials introduced by the FDA in 2006?
To address the challenges in drug development, aiming to gather pharmacokinetic and
pharmacodynamic data early on and identify potential drug candidates for further study.
How does the use of very low drug doses in phase zero trials contribute to their
advantages?
Makes them less resource and time-intensive and usually involves no toxicity, allowing
for the selection of promising drug candidates without starting over from scratch.
What ethical considerations must be addressed in phase zero trials?
Must be aware that there is no possibility of therapeutic efficacy, and their participation
may disqualify them from subsequent clinical trials. Physicians must ensure a smooth
transition to appropriate treatments if needed.
What is the main goal of phase zero trials in drug development?
To gather pharmacokinetic and pharmacodynamic data early in drug development to
identify potential drug candidates for further study.
How did the cost of drug development change between 1985 and 2000, and what
impact did it have on drug development?
Increased by 55% between 1985 and 2000, making drug development riskier and more
expensive.
What advantage does using low drug doses in phase zero trials offer over
traditional drug development approaches?
